Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2018 Filed Feb 14, 2018 23:23 UTC |
SULIMAN SHEHNAAZSVP, Corp Dev & Strategy
|
GrantOrdinary Shares | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002128 · edgar.xml · nonDerivative · entry 2 SULIMAN SHEHNAAZ · CIK 0001713070 · SVP, Corp Dev & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 F1 · shares: On August 1, 2017, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions from August 1, 2017 through December 31, 2020 and continued employment. On February 12, 2018, the performance conditions applicable to 25,000 shares were deemed achieved and such shares will vest on February 20, 2018. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:23 UTC |
SULIMAN SHEHNAAZSVP, Corp Dev & Strategy
|
GrantOrdinary Shares | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002128 · edgar.xml · nonDerivative · entry 1 SULIMAN SHEHNAAZ · CIK 0001713070 · SVP, Corp Dev & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:21 UTC |
PASQUALONE FRANKSVP, Chief Comm Ops Officer
|
GrantOrdinary Shares | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002124 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP, Chief Comm Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,360 Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:20 UTC |
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc
|
GrantOrdinary Shares | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002122 · edgar.xml · nonDerivative · entry 1 HAUMANN BRETT K · CIK 0001607733 · SVP Clin Dev & Chief Med Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,496 Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:19 UTC |
GALA RENEE DSVP, Chief Financial Officer
|
GrantOrdinary Shares | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002120 · edgar.xml · nonDerivative · entry 1 GALA RENEE D · CIK 0001607737 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,794 Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 16:38 UTC |
HEGDE SHARATHCHANDRA SSVP, Research
|
Tax withholdingOrdinary Shares | 5,177 | $28.58 | $147,958.66 |
DisclosureSEC source: 0001179110-17-014563 · edgar.xml · nonDerivative · entry 1 HEGDE SHARATHCHANDRA S · CIK 0001668696 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,960 Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 16:40 UTC |
WORBOYS PHILIP DSVP, Translational Science
|
Tax withholdingOrdinary Shares | 5,503 | $28.58 | $157,275.74 |
DisclosureSEC source: 0001179110-17-014567 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Translational Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,129 Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 16:39 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
Tax withholdingOrdinary Shares | 5,014 | $28.58 | $143,300.12 |
DisclosureSEC source: 0001179110-17-014565 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,306 Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 16:40 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
Tax withholdingOrdinary Shares | 7,079 | $28.58 | $202,317.82 |
DisclosureSEC source: 0001179110-17-014566 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,248 Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 21:38 UTC |
PASQUALONE FRANKSVP, Chief Comm Ops Officer
|
Tax withholdingOrdinary Shares | 5,820 | $28.58 | $166,335.60 |
DisclosureSEC source: 0001179110-17-014564 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP, Chief Comm Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,360 Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 21:37 UTC |
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc
|
Tax withholdingOrdinary Shares | 7,846 | $28.58 | $224,238.68 |
DisclosureSEC source: 0001179110-17-014562 · edgar.xml · nonDerivative · entry 1 HAUMANN BRETT K · CIK 0001607733 · SVP Clin Dev & Chief Med Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,496 Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 21:35 UTC |
GALA RENEE DSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 6,753 | $28.58 | $193,000.74 |
DisclosureSEC source: 0001179110-17-014561 · edgar.xml · nonDerivative · entry 1 GALA RENEE D · CIK 0001607737 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,794 Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:53 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
SaleOrdinary Shares | 14,670 | $30.77 | $451,350.42 |
DisclosureSEC source: 0001179110-17-012159 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,327 F1 · price: This transaction was executed in multiple trades at prices from $30.69 to $30.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 21:04 UTC |
PASQUALONE FRANKSVP, Chief Comm Ops Officer
|
PurchaseOrdinary Shares | 4,000 | $26.34 | $105,358.80 |
DisclosureSEC source: 0001179110-17-011785 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP, Chief Comm Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,180 F1 · price: Represents the weighted average purchase price per share for the open market purchase on August 21, 2017. The shares were purchased at prices ranging from $26.2499 to $26.4541 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 20, 2017 Filed Aug 22, 2017 18:28 UTC |
HEGDE SHARATHCHANDRA SSVP, Research
|
Tax withholdingOrdinary Shares | 5,176 | $27.40 | $141,822.40 |
DisclosureSEC source: 0001179110-17-011748 · edgar.xml · nonDerivative · entry 1 HEGDE SHARATHCHANDRA S · CIK 0001668696 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,137 Read SEC document |
| August 20, 2017 Filed Aug 22, 2017 18:31 UTC |
WORBOYS PHILIP DSVP, Translational Science
|
Tax withholdingOrdinary Shares | 5,502 | $27.40 | $150,754.80 |
DisclosureSEC source: 0001179110-17-011752 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Translational Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,632 Read SEC document |
| August 20, 2017 Filed Aug 22, 2017 18:30 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
Tax withholdingOrdinary Shares | 5,013 | $27.40 | $137,356.20 |
DisclosureSEC source: 0001179110-17-011750 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,320 Read SEC document |
| August 20, 2017 Filed Aug 22, 2017 18:30 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
Tax withholdingOrdinary Shares | 7,079 | $27.40 | $193,964.60 |
DisclosureSEC source: 0001179110-17-011751 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,997 Read SEC document |
| August 20, 2017 Filed Aug 22, 2017 22:29 UTC |
PASQUALONE FRANKSVP, Chief Comm Ops Officer
|
Tax withholdingOrdinary Shares | 5,820 | $27.40 | $159,468.00 |
DisclosureSEC source: 0001179110-17-011749 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP, Chief Comm Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,180 Read SEC document |
| August 20, 2017 Filed Aug 22, 2017 22:28 UTC |
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc
|
Tax withholdingOrdinary Shares | 7,064 | $27.40 | $193,553.60 |
DisclosureSEC source: 0001179110-17-011747 · edgar.xml · nonDerivative · entry 1 HAUMANN BRETT K · CIK 0001607733 · SVP Clin Dev & Chief Med Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,342 Read SEC document |
| August 20, 2017 Filed Aug 22, 2017 22:27 UTC |
GALA RENEE DSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 6,752 | $27.40 | $185,004.80 |
DisclosureSEC source: 0001179110-17-011746 · edgar.xml · nonDerivative · entry 1 GALA RENEE D · CIK 0001607737 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,547 Read SEC document |
| August 11, 2017 Filed Aug 11, 2017 22:26 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
PurchaseOrdinary Shares | 10,000 | $24.50 | $245,000.00 |
DisclosureSEC source: 0001179110-17-011428 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 866,377 Read SEC document |
| August 11, 2017 Filed Aug 11, 2017 18:33 UTC |
Fore HenriettaDirector
|
PurchaseOrdinary Shares | 6,000 | $23.99 | $143,932.20 |
DisclosureSEC source: 0001179110-17-011429 · edgar.xml · nonDerivative · entry 1 Fore Henrietta · CIK 0001503774 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 F1 · price: Represents the weighted average purchase price per share for the open market purchase on August 11, 2017. The shares were purchased at prices ranging from $23.98 to $23.989 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 11, 2017 Filed Aug 14, 2017 20:00 UTC |
WHITESIDES GEORGE MDirector
|
PurchaseOrdinary Shares | 4,000 | $24.69 | $98,764.00 |
DisclosureSEC source: 0001179110-17-011479 · edgar.xml · nonDerivative · entry 1 WHITESIDES GEORGE M · CIK 0001233438 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 4,000 Read SEC document |
| August 11, 2017 Filed Aug 14, 2017 19:57 UTC |
MALKIEL BURTON GDirector
|
PurchaseOrdinary Shares | 15,000 | $24.59 | $368,815.50 |
DisclosureSEC source: 0001179110-17-011478 · edgar.xml · nonDerivative · entry 2 MALKIEL BURTON G · CIK 0001184677 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 15,000 F2 · price: Represents the weighted average purchase price per share for the open market purchase on August 11, 2017. The shares were purchased at prices ranging from $24.36 to $24.903 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 11, 2017 Filed Aug 14, 2017 19:57 UTC |
MALKIEL BURTON GDirector
|
PurchaseOrdinary Shares | 15,000 | $24.59 | $368,854.50 |
DisclosureSEC source: 0001179110-17-011478 · edgar.xml · nonDerivative · entry 1 MALKIEL BURTON G · CIK 0001184677 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,571 F1 · price: Represents the weighted average purchase price per share for the open market purchase on August 11, 2017. The shares were purchased at prices ranging from $24.35 to $24.921 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 22:12 UTC |
SULIMAN SHEHNAAZSVP, Corp Dev & Strategy
|
GrantShare Option (Right to Buy) · Derivative | 170,000 | $0.00 Strike: $31.93 | $0.00 |
DisclosureSEC source: 0001179110-17-011060 · edgar.xml · derivative · entry 2 SULIMAN SHEHNAAZ · CIK 0001713070 · SVP, Corp Dev & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,000 Underlying: Ordinary Shares · 170,000 shares Expires 2027-07-31 F1 · derivative.exercise_date: This option may be exercised with respect to the first 25% of the shares subject to this option when optionee completes 12 months of continuous service after the Grant Date. This option may be exercised with respect to an additional 1/48th of the shares subject to this option when optionee completes each month of continuous service thereafter. The option shall be fully vested and exercisable on the 4-year anniversary of the Grant Date provided optionee has remained in continuous service through such date. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 22:12 UTC |
SULIMAN SHEHNAAZSVP, Corp Dev & Strategy
|
GrantOrdinary Shares | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-011060 · edgar.xml · nonDerivative · entry 1 SULIMAN SHEHNAAZ · CIK 0001713070 · SVP, Corp Dev & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| May 20, 2017 Filed May 23, 2017 19:59 UTC |
HEGDE SHARATHCHANDRA SSVP, Research
|
Tax withholdingOrdinary Shares | 5,177 | $36.83 | $190,668.91 |
DisclosureSEC source: 0001179110-17-007878 · edgar.xml · nonDerivative · entry 1 HEGDE SHARATHCHANDRA S · CIK 0001668696 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,313 Read SEC document |
| May 20, 2017 Filed May 23, 2017 20:01 UTC |
WORBOYS PHILIP DSVP, Translational Science
|
Tax withholdingOrdinary Shares | 5,503 | $36.83 | $202,675.49 |
DisclosureSEC source: 0001179110-17-007883 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Translational Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,134 F1 · balance_after: Includes 1,702 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2017. Read SEC document |
| May 20, 2017 Filed May 23, 2017 20:00 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
Tax withholdingOrdinary Shares | 5,014 | $36.83 | $184,665.62 |
DisclosureSEC source: 0001179110-17-007880 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,333 Read SEC document |
| May 20, 2017 Filed May 23, 2017 20:00 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
Tax withholdingOrdinary Shares | 7,079 | $36.83 | $260,719.57 |
DisclosureSEC source: 0001179110-17-007881 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,076 F1 · balance_after: Includes 1,702 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2017. Read SEC document |
| May 20, 2017 Filed May 24, 2017 00:01 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 15,460 | $36.83 | $569,391.80 |
DisclosureSEC source: 0001179110-17-007882 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 856,377 F1 · balance_after: Includes 1,702 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2017. Read SEC document |
| May 20, 2017 Filed May 23, 2017 23:59 UTC |
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc
|
Tax withholdingOrdinary Shares | 7,065 | $36.83 | $260,203.95 |
DisclosureSEC source: 0001179110-17-007877 · edgar.xml · nonDerivative · entry 1 HAUMANN BRETT K · CIK 0001607733 · SVP Clin Dev & Chief Med Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,406 Read SEC document |
| May 20, 2017 Filed May 24, 2017 00:00 UTC |
PASQUALONE FRANKSVP, Chief Comm Ops Officer
|
Tax withholdingOrdinary Shares | 5,820 | $36.83 | $214,350.60 |
DisclosureSEC source: 0001179110-17-007879 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP, Chief Comm Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,000 F1 · balance_after: Includes 1,702 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2017. Read SEC document |
| May 20, 2017 Filed May 23, 2017 23:58 UTC |
GALA RENEE DSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 6,753 | $36.83 | $248,712.99 |
DisclosureSEC source: 0001179110-17-007876 · edgar.xml · nonDerivative · entry 1 GALA RENEE D · CIK 0001607737 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,299 F1 · balance_after: Includes 1,702 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2017. Read SEC document |
| May 17, 2017 Filed May 18, 2017 22:02 UTC |
Gunderson Robert V JRDirector
|
GrantOrdinary Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-007539 · edgar.xml · nonDerivative · entry 1 Gunderson Robert V JR · CIK 0001302450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,059 Read SEC document |
| May 17, 2017 Filed May 18, 2017 22:02 UTC |
BROSHY ERANDirector
|
GrantOrdinary Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-007537 · edgar.xml · nonDerivative · entry 1 BROSHY ERAN · CIK 0001256230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Read SEC document |
| May 17, 2017 Filed May 18, 2017 18:05 UTC |
WHITESIDES GEORGE MDirector
|
GrantOrdinary Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-007546 · edgar.xml · nonDerivative · entry 1 WHITESIDES GEORGE M · CIK 0001233438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,392 Read SEC document |
| May 17, 2017 Filed May 18, 2017 18:03 UTC |
MALKIEL BURTON GDirector
|
GrantOrdinary Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-007540 · edgar.xml · nonDerivative · entry 1 MALKIEL BURTON G · CIK 0001184677 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,571 Read SEC document |
| May 17, 2017 Filed May 18, 2017 18:05 UTC |
RINGROSE PETER SDirector
|
GrantOrdinary Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-007545 · edgar.xml · nonDerivative · entry 1 RINGROSE PETER S · CIK 0001199298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,428 Read SEC document |
| May 17, 2017 Filed May 18, 2017 22:03 UTC |
MITCHELL DEAN JDirector
|
GrantOrdinary Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-007541 · edgar.xml · nonDerivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Read SEC document |
| May 17, 2017 Filed May 18, 2017 22:05 UTC |
YOUNG WILLIAM DDirector
|
GrantOrdinary Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-007547 · edgar.xml · nonDerivative · entry 1 YOUNG WILLIAM D · CIK 0001217420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,124 Read SEC document |
| May 17, 2017 Filed May 18, 2017 18:02 UTC |
Fore HenriettaDirector
|
GrantOrdinary Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-007538 · edgar.xml · nonDerivative · entry 1 Fore Henrietta · CIK 0001503774 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Read SEC document |
| May 17, 2017 Filed May 18, 2017 22:04 UTC |
Molineaux SusanDirector
|
GrantOrdinary Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-007543 · edgar.xml · nonDerivative · entry 1 Molineaux Susan · CIK 0001553389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Read SEC document |
| May 17, 2017 Filed May 18, 2017 22:05 UTC |
O'Connor DonalDirector
|
GrantOrdinary Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-007544 · edgar.xml · nonDerivative · entry 1 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| March 07, 2017 Filed Mar 8, 2017 23:11 UTC |
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc
|
SaleOrdinary Shares | 424 | $30.80 | $13,059.20 |
DisclosureSEC source: 0001179110-17-004273 · edgar.xml · nonDerivative · entry 2 HAUMANN BRETT K · CIK 0001607733 · SVP Clin Dev & Chief Med Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,471 Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 23:11 UTC |
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc
|
SaleOrdinary Shares | 13,576 | $31.52 | $427,915.52 |
DisclosureSEC source: 0001179110-17-004273 · edgar.xml · nonDerivative · entry 1 HAUMANN BRETT K · CIK 0001607733 · SVP Clin Dev & Chief Med Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,895 F1 · price: This transaction was executed in multiple trades at prices from $31.18 to $32.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 19:05 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
SaleOrdinary Shares | 26,829 | $31.86 | $854,771.94 |
DisclosureSEC source: 0001179110-17-004176 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,453 F1 · price: This transaction was executed in multiple trades at prices from $31.86 to $31.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transactions set forth in footnotes (1) through (3) to this Form 4 were effected. Read SEC document |
| February 20, 2017 Filed Feb 22, 2017 19:06 UTC |
HEGDE SHARATHCHANDRA SSVP, Research
|
Tax withholdingOrdinary Shares | 10,138 | $33.78 | $342,461.64 |
DisclosureSEC source: 0001179110-17-002990 · edgar.xml · nonDerivative · entry 1 HEGDE SHARATHCHANDRA S · CIK 0001668696 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,490 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.